Difference between revisions of "Conservative victims of hospital protocols for Covid"

From Conservapedia
Jump to: navigation, search
(Common in hospital protocols for Covid is Fauci-promoted remdesivir, which profits its patent-holders and causes organ damage, without significantly alleviating Covid.)
(In May 2020, "Fauci’s Promotional Hype Catapults Gilead’s Remdesivir.")
Line 4: Line 4:
 
*Rep. Jim Hagedorn (R-MN), admitted to the hospital merely "as a precaution" amid merely mild symptoms<ref>https://edition.cnn.com/2022/02/18/politics/jim-hagedorn-dies-republican-minnesota-congressman/index.html</ref>
 
*Rep. Jim Hagedorn (R-MN), admitted to the hospital merely "as a precaution" amid merely mild symptoms<ref>https://edition.cnn.com/2022/02/18/politics/jim-hagedorn-dies-republican-minnesota-congressman/index.html</ref>
  
Common in hospital protocols for [[COVID-19|Covid]] is [[Fauci]]-promoted [[remdesivir]], which profits its [[patent]]-holders and causes organ damage, without significantly alleviating Covid.
+
Common in hospital protocols for [[COVID-19|Covid]] is [[Fauci]]-promoted [[remdesivir]], which profits its [[patent]]-holders and causes organ damage, without significantly alleviating Covid. In May 2020, "Fauci’s Promotional Hype Catapults Gilead’s Remdesivir."<ref>https://ahrp.org/faucis-promotional-hype-catapults-gileads-remdesivir/</ref>
 
== References ==
 
== References ==
 
{{reflist}}
 
{{reflist}}
 
{{coronavirus}}
 
{{coronavirus}}

Revision as of 19:41, June 19, 2022

Conservative victims of hospital protocols for Covid, which typically blocks access by the patient to hydroxychloroquine and ivermectin despite many studies showing their effectiveness, include the following:

  • Herman Cain
  • Phil Valentine
  • Rep. Jim Hagedorn (R-MN), admitted to the hospital merely "as a precaution" amid merely mild symptoms[1]

Common in hospital protocols for Covid is Fauci-promoted remdesivir, which profits its patent-holders and causes organ damage, without significantly alleviating Covid. In May 2020, "Fauci’s Promotional Hype Catapults Gilead’s Remdesivir."[2]

References